Drugs / Au-TMP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07562841 | Apr 2026 → Apr 2028 expected | melanoma | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Au-TMP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07562841 ↗ |
| Modality | Other / unclassified | “Au-TMP nanoparticles serve as an innovative radiosensitizing platform” NCT07562841 ↗ |
| Route | Other | “single intratumoral injection of Au-TMP” NCT07562841 ↗ |